EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSMLUG00000014226
Gene Symbol: PSMD6
2 Cross references
212 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 7

Ensembl ID : ENSMLUG00000005416
Gene Symbol: PSMD7
2 Cross references
243 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSMLUG00000009902
Gene Symbol: PSMD8
2 Cross references
202 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSMLUG00000014282
Gene Symbol: PSMB11
4 Cross references
227 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSMLUG00000012929
Gene Symbol: PRMT5
2 Cross references
198 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSMLUG00000001590
Gene Symbol: PRKCA
2 Cross references
289 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSMLUG00000006872
Gene Symbol: PRKCB
2 Cross references
286 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSMLUG00000000929
Gene Symbol: PRKCD
2 Cross references
280 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSMLUG00000007061
Gene Symbol: PRKCE
2 Cross references
316 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSMLUG00000003390
Gene Symbol: PRKCH
2 Cross references
237 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSMLUG00000015500
Gene Symbol: PRKCG
2 Cross references
198 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSMLUG00000006267
Gene Symbol: PRKCI
2 Cross references
195 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).